Rehwald U - Search Results

1

Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group.

Rehwald U, Schulz H, Reiser M, Sieber M, Staak JO, Morschhauser F, Driessen C, Rudiger T, Muller-Hermelink K, Diehl V, Engert A; German Hodgkin Lymphoma Study Group (GHSG). Rehwald U, et al. Blood. 2003 Jan 15;101(2):420-4. doi: 10.1182/blood.V101.2.420. Blood. 2003. PMID: 12509381 Free article. Clinical Trial.

2

Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia.

Schulz H, Klein SK, Rehwald U, Reiser M, Hinke A, Knauf WU, Aulitzky WE, Hensel M, Herold M, Huhn D, Hallek M, Diehl V, Engert A; German CLL Study Group. Schulz H, et al. Among authors: rehwald u. Blood. 2002 Nov 1;100(9):3115-20. doi: 10.1182/blood-2002-03-0972. Blood. 2002. PMID: 12384407 Free article. Clinical Trial.

3

Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).

Schulz H, Rehwald U, Morschhauser F, Elter T, Driessen C, Rüdiger T, Borchmann P, Schnell R, Diehl V, Engert A, Reiser M. Schulz H, et al. Among authors: rehwald u. Blood. 2008 Jan 1;111(1):109-11. doi: 10.1182/blood-2007-03-078725. Epub 2007 Oct 15. Blood. 2008. PMID: 17938252 Free article. Clinical Trial.

4

BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection.

Hartmann P, Rehwald U, Salzberger B, Franzen C, Sieber M, Wöhrmann A, Diehl V. Hartmann P, et al. Among authors: rehwald u. Ann Oncol. 2003 Oct;14(10):1562-9. doi: 10.1093/annonc/mdg408. Ann Oncol. 2003. PMID: 14504059 Free article. Clinical Trial.

5

Current treatment strategies for patients with Hodgkin's lymphoma and HIV infection.

Hartmann P, Rehwald U, Salzberger B, Franzen C, Diehl V. Hartmann P, et al. Among authors: rehwald u. Expert Rev Anticancer Ther. 2004 Jun;4(3):401-10. doi: 10.1586/14737140.4.3.401. Expert Rev Anticancer Ther. 2004. PMID: 15161439 Review.

6

Sensitivity analysis of cost factors for various therapy options in the treatment of follicular lymphoma.

Schmitz S, Aly F, Steinmetz T, Diehl V, Rehwald U. Schmitz S, et al. Among authors: rehwald u. Onkologie. 2006 Jun;29(6):258-64. doi: 10.1159/000093312. Epub 2006 Jun 12. Onkologie. 2006. PMID: 16770087

7

[Reduced-dose adjuvant CMF-chemotherapy combined with postoperative irradiation in breast cancer with lymphatic metastases. A prospective study of 45 patients].

Sauerwein W, Nitz U, Rehwald U, Lapukins Z, Schmitt G, Scherer E. Sauerwein W, et al. Among authors: rehwald u. Strahlentherapie. 1985 Jun;161(6):354-61. Strahlentherapie. 1985. PMID: 3839325 German.

8

[Results of standardized postoperative radiotherapy in circumscribed breast cancer. A retrospective study of 432 patients].

Sauerwein W, Rehwald U, Müller RD. Sauerwein W, et al. Among authors: rehwald u. Strahlentherapie. 1984 Mar;160(3):137-43. Strahlentherapie. 1984. PMID: 6729853 German.

9

[Induction of solid tumors by ionizing radiation].

Sauerwein W, Schmitt G, Rehwald U. Sauerwein W, et al. Among authors: rehwald u. Strahlentherapie. 1984 Aug;160(8):497-504. Strahlentherapie. 1984. PMID: 6474524 German.

10

[Objective and quantitative study of the sensomotor effect of magnetic fields on man].

Prehn H, Herget M, Kempe L, Rehwald U, Will BE. Prehn H, et al. Among authors: rehwald u. Biomed Tech (Berl). 1986 Apr;31(4):74-8. Biomed Tech (Berl). 1986. PMID: 3719046 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters